Comparison of the AdvanSure Human Papillomavirus Screening Real-Time PCR the Abbott RealTime High Risk Human Papillomavirus Test and the Hybrid Capture Human Papillomavirus DNA Test for the Detection of Human Papillomavirus

摘要

BackgroundWe evaluated the performance of various commercial assays for the molecular detection of human papillomavirus (HPV); the recently developed AdvanSure HPV Screening real-time PCR assay (AdvanSure PCR) and the Abbott RealTime High Risk HPV PCR assay (Abbott PCR) were compared with the Hybrid Capture 2 HPV DNA Test (HC2).